Israel Englander Infla Rx N.V. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Infla Rx N.V. stock. As of the latest transaction made, Millennium Management LLC holds 12,220 shares of IFRX stock, worth $27,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,220

Holding current value

$27,372

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.34 - $1.73 $16,374 - $21,140	12,220 New	12,220 $18,000
Q1 2024 May 15, 2024	SELL	$1.47 - $2.03 $207,233 - $286,179	-140,975 Reduced 50.18%	139,957 $215,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.75 $112,723 - $247,992	-90,179 Reduced 24.3%	280,932 $457,000
Q2 2023 Aug 14, 2023	BUY	$2.05 - $6.1 $760,777 - $2.26 Million	371,111 New	371,111 $1.66 Million
Q4 2022 Feb 14, 2023	SELL	$2.11 - $3.25 $5,718 - $8,807	-2,710 Reduced 2.18%	121,693 $377,000
Q3 2022 Nov 14, 2022	SELL	$1.32 - $3.14 $106,217 - $252,669	-80,468 Reduced 39.28%	124,403 $328,000
Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.9 $23,295 - $56,745	29,866 Added 17.07%	204,871 $297,000
Q1 2022 May 16, 2022	BUY	$1.83 - $4.48 $294,888 - $721,911	161,141 Added 1162.3%	175,005 $320,000
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $75,707 - $179,765	-32,216 Reduced 69.91%	13,864 $66,000
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.03 $30,460 - $41,020	13,538 Added 41.6%	46,080 $119,000
Q2 2021 Aug 16, 2021	BUY	$2.72 - $4.04 $5,513 - $8,189	2,027 Added 6.64%	32,542 $97,000
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $110,464 - $193,465	30,515 New	30,515 $119,000
Q1 2020 May 14, 2020	SELL	$2.65 - $6.08 $318,185 - $730,025	-120,070 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.2 - $4.54 $88,992 - $183,647	-40,451 Reduced 25.2%	120,070 $475,000
Q3 2019 Nov 14, 2019	SELL	$2.47 - $3.51 $1.77 Million - $2.52 Million	-717,303 Reduced 81.71%	160,521 $396,000
Q2 2019 Aug 15, 2019	BUY	$3.06 - $51.61 $2.66 Million - $44.9 Million	870,535 Added 11943.13%	877,824 $2.77 Million
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $92,041 - $1.55 Million	-30,079 Reduced 80.49%	7,289 $7.8 Million
Q1 2019 May 14, 2019	SELL	$31.16 - $48.62 $1.08 Million - $1.69 Million	-34,785 Reduced 48.21%	37,368 $1.41 Million
Q4 2018 Feb 14, 2019	BUY	$23.33 - $36.37 $258,496 - $402,979	11,080 Added 18.14%	72,153 $2.62 Million
Q3 2018 Nov 14, 2018	BUY	$29.34 - $35.0 $48,645 - $58,030	1,658 Added 2.79%	61,073 $2.1 Million
Q2 2018 Aug 14, 2018	BUY	$27.33 - $41.46 $1.62 Million - $2.46 Million	59,415 New	59,415 $1.92 Million
Q1 2018 May 15, 2018	SELL	$20.21 - $32.0 $1.03 Million - $1.62 Million	-50,742 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.55 - $23.99 $738,296 - $1.22 Million	50,742	50,742 $1.06 Million

Others Institutions Holding IFRX

# of Institutions

Shares Held

12.9M

Call Options Held

19.3K

Put Options Held

View Full List

About InflaRx N.V.

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

More about IFRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account